Targeting oncofetal high mobility group A2 (HMGA2) to increase sensitivity to temozolomide (TMZ) in glioblastoma (GB) cells

Authors :: Thomas Klonisch
Brian B. Hasinoff
Suchitra Natarajan
Marc R. Del Bigio
Hugo Bergen
Inder M. Verma
Thatchawan Thanasupawat
Sabine Hombach-Klonisch
Marshall Pitz
Jerry Krcek
Amy Rommel
Source :: Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 41:S3-S4
Publication Year :: 2014
Publisher :: Cambridge University Press (CUP), 2014.

Subjects :: Temozolomide
biology
Chemistry
General Medicine
medicine.disease
Virology
HMGA2
High-mobility group
Neurology
biology.protein
medicine
Cancer research
Neurology (clinical)
Sensitivity (control systems)
medicine.drug
Glioblastoma

ISSN :: 20570155 and 03171671
Volume :: 41
Database :: OpenAIRE
Journal :: Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
Accession number :: edsair.doi...........b8427fcf3e34e567a24b3a258bcb71f9

Tools